-

KBRA Releases Research – Synthetic Risk Transfers Taking the Spotlight

NEW YORK--(BUSINESS WIRE)--KBRA releases research that examines synthetic risk transfer (SRT) transactions. Dialogue with market participants regarding SRTs has increased ahead of upcoming Basel 3 regulations set to take effect in mid-2025.

The regulations will substantially change how risk-weighted assets are calculated, resulting in rising capital charges for various portfolio assets. The combination of higher expected regulatory risk weightings and substantial legacy portfolio holdings with unfavorable prospects for sale—since the assets are priced below prevailing higher interest rates—is expected to further encourage risk transfer efforts.

KBRA’s approach to SRTs involves the utilization of asset-specific methodologies applicable to cash securitizations, with consideration given to transaction structures that continue to evolve. KBRA will evaluate features that provide additional credit support as well as key counterparties, in determining whether credit-linked notes are not constrained by the credit quality of the issuer.

KBRA has rated several SRT transactions, with market conditions suggesting a significant pickup in the use of these structures going forward. The report includes a list of KBRA-rated transactions.

Click here to view the report.

About KBRA

KBRA is a full-service credit rating agency registered in the U.S., the EU, and the UK, and is designated to provide structured finance ratings in Canada. KBRA’s ratings can be used by investors for regulatory capital purposes in multiple jurisdictions.

Contacts

Contacts

Sharif Mahdavian, RMBS
+1 646-731-2301
sharif.mahdavian@kbra.com

Killian Walsh, European Structured Finance
+353 1 588 1184
killian.walsh@kbra.com

Jack Kahan, Head of Global RMBS
+1 646-731-2486
jack.kahan@kbra.com

Eric Neglia, Head of Commercial and Consumer ABS
+1 646-731-2456
eric.neglia@kbra.com

John Hogan, Global Head of Ratings Legal
+44 20 8148 1040
john.hogan@kbra.com

Business Development Contacts

Rosemary Kelley, Senior Managing Director
+1 646-731-2337
rosemary.kelley@kbra.com

Mauricio Noé, Co-Head of Europe
+44 20 8148 1010
mauricio.noe@kbra.com

KBRA

Details
Headquarters: New York City, New York
CEO: Jim Nadler
Employees: 400+
Organization: PRI

Release Versions

Contacts

Contacts

Sharif Mahdavian, RMBS
+1 646-731-2301
sharif.mahdavian@kbra.com

Killian Walsh, European Structured Finance
+353 1 588 1184
killian.walsh@kbra.com

Jack Kahan, Head of Global RMBS
+1 646-731-2486
jack.kahan@kbra.com

Eric Neglia, Head of Commercial and Consumer ABS
+1 646-731-2456
eric.neglia@kbra.com

John Hogan, Global Head of Ratings Legal
+44 20 8148 1040
john.hogan@kbra.com

Business Development Contacts

Rosemary Kelley, Senior Managing Director
+1 646-731-2337
rosemary.kelley@kbra.com

Mauricio Noé, Co-Head of Europe
+44 20 8148 1010
mauricio.noe@kbra.com

More News From KBRA

KBRA Assigns Preliminary Ratings to Sequoia Mortgage Trust 2026-INV2 (SEMT 2026-INV2)

NEW YORK--(BUSINESS WIRE)--KBRA assigns preliminary ratings to 71 classes of mortgage pass-through certificates from Sequoia Mortgage Trust 2026-INV2 (SEMT 2026-INV2). The transaction consists of 1,118 investment property mortgages with an aggregate principal balance of $438.4 million as of the March 1, 2026 cut-off date. The collateral is characterized by a weighted average (WA) original credit score of 770 and moderate borrower equity, with a WA original LTV and WA original CLTV of 73.2%. KBR...

KBRA Assigns Preliminary Ratings to Research-Driven Pagaya Motor Asset Trust 2026-R1 and Research-Driven Pagaya Motor Trust 2026-R1

NEW YORK--(BUSINESS WIRE)--KBRA assigns preliminary ratings to six classes of notes issued by Research-Driven Pagaya Motor Asset Trust 2026-R1 and Research-Driven Pagaya Motor Trust 2026-R1 (collectively “RPM 2026-R1”), an auto loan ABS transaction. RPM 2026-R1 has initial credit enhancement levels of 35.69% for the Class A notes to 2.65% for the Class E-2 notes. Credit enhancement is comprised of overcollateralization, subordination of junior note classes (except for the Class E-2 notes), a ca...

KBRA Releases Research – What’s up, Doc – Medical Professional Mortgages, A New Niche in RMBS?

NEW YORK--(BUSINESS WIRE)--KBRA releases research assessing the characteristics of medical professional mortgage (MPM) loans, with a focus on their potential role as a niche collateral segment within the prime private label residential mortgage-backed securities (RMBS) market. MPMs, often called physician or doctor loans, are specialized prime mortgage programs designed for medical professionals whose early-career financial profiles often include high student debt, limited savings, and reliance...
Back to Newsroom